Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis

Leishmaniasis affects around 12 million people worldwide and is estimated to cause the ninth-largest disease burden. There are three main forms of the disease, visceral (VL), cutaneous (CL), and mucocutaneous (MCL), leading to more than one million new cases every year and several thousand deaths. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilbao-Ramos, Pablo, Serrano, Dolores R., Ruiz Saldaña, Helga Karina, Torrado, Juan J., Bolás-Fernández, Francisco, Dea-Ayuela, María Auxiliadora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144553/
https://www.ncbi.nlm.nih.gov/pubmed/32204358
http://dx.doi.org/10.3390/molecules25061394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144553/
https://www.ncbi.nlm.nih.gov/pubmed/32204358
http://dx.doi.org/10.3390/molecules25061394

Ejemplares similares